This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
Bailey DB, Rassnick KM, Erb HN et al.(2004) Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors.American Journal of Veterinary Research65, 1502–1507
Skorupski KA, Uhl JM, Szivek A et al. (2016) Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.Veterinary and Comparative Oncology14, 81–87
BergmanPJ ,MacEwenEG ,KurzmanID et al. (1996)Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993).Journal of Veterinary Internal Medicine10,76–81
Charney SC, Bergman PJ, McKnight JA et al.(2005) Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: a retrospective analysis of 12 cases (1997–2002) Veterinary and Comparative Oncology10, 171–181
Floch F, Boissy L, Lanore D et al. (2019) Evaluation of intracavitary carboplatin chemotherapy for treatment of pleural carcinomatosis in cats: a retrospective study of eight cases. Journal of Feline Medicine and Surgery22, 84–90
HahnKA ,McEnteeMF ,DanielGB et al.(1997)Hematologic and systemic toxicoses associated with carboplatin administration in cats.American Journal of Veterinary Research58,677–679
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
